Pramana (working name) by VedAGI

Prove and release life-sciences evidence figures.

Pramana (working name) helps life-sciences teams prove and release evidence-pack figures. It recalculates numbers from the source, labels estimates, and locks them until a named person signs. Anyone can check the receipt in a browser.

Who it is for

Built for the people who send and review the figures.

Built for market-access and HEOR directors, payer pricing leads, and procurement and security reviewers.

Pramana (working name) supports trust through recalculating figures from source, labeled estimates, a named signer and a browser-verifiable receipt. A person stays in charge.

Market access budget-impact verification starts with source figures, clearly labeled estimates and a named signer. For teams evaluating a payer dossier figure lock, the receipt makes the signed result reviewable.

Status

Where it stands today.

United States: production candidate

The US workflow starts with the AMCP budget-impact table.

Being added, not live today

A figure-record version chain, with a version two receipt citing version one.

Name

A working name.

Pramana (working name) is pending trademark counsel review. The name may change.

Benefits

Benefits and expected savings

Independent research found technical errors in 39 of 41 company economic models in NICE’s 2017 appraisals (95 percent). Source: doi:10.1017/s0266462320000422.

Field audits summarized by Panko found errors in at least 86 percent of spreadsheets. Source: Panko, arXiv 0802.3457.

Target: Pramana (working name) is built to catch model errors before submission, where a peer-reviewed study found errors in 95% of company models submitted to NICE in 2017.

Planned

Planned: Faster evidence-pack drafting with approved wording

We plan to let your team create, edit and approve wording templates and reuse verified records with links back to their sources. The goal is faster drafting and more consistent wording.

Templates and reused answers would not create figures or turn cached text into evidence. Estimates would remain labeled, missing evidence would still trigger refusal, and a named person would still sign off before release.

This extension is planned and is not available today. It means reusing approved business information, not training an AI model. It would not involve sharing information between companies.

Compliance

Regulatory compliance and fiscal responsibility

Pramana (working name) is designed to support 21 CFR Part 11-style controls for electronic records and signatures by locking recomputed figures only after a named signer acts, with a receipt that links the signature to the released values. Source: 21 CFR Part 11.

Pramana (working name) is designed to support FDA ALCOA data-integrity expectations by making each released figure attributable to a signer, contemporaneous with the lock, and accurate to a recomputation from the stated source workbook. Source: FDA data integrity Q&A.

Pramana (working name) is designed to support AMCP Format 5.0 economic-evidence needs by locking budget-impact figures to their source model before a dossier version leaves the company. Source: AMCP Format 5.0 (PDF).

Pramana (working name) is designed to support CMS Medicare Drug Price Negotiation information submissions by keeping evidence-pack figures locked, estimate-labeled, and receipt-backed so manufacturer data packages can be reconstructed without silent edits. Source: CMS Medicare Drug Price Negotiation guidance.

Pramana (working name) is designed to support EU HTA Regulation (EU) 2021/2282 joint-assessment evidence discipline, where 13 JCAs were already initiated in 2025, by freezing figure versions and receipts so clinical-economic numbers do not drift between national reuse cycles. Source: EIPG HTA Regulation report.

Discuss your evidence pack

Discuss your evidence pack with VedAGI.

VedAGI. Intelligence for Humanity.